Abstract
IntroductionIn immune-mediated inflammatory diseases, there is a lack of -estimates of glucocorticoid dose–response diabetes risk that consider changes in prescribed dose over time and disease activity.Research design and methodsPopulation-based longitudinal...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have